{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:08:09Z","timestamp":1772910489683,"version":"3.50.1"},"reference-count":131,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UID\/BIO\/04469\/2019"],"award-info":[{"award-number":["UID\/BIO\/04469\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["SFRH\/BD\/130913\/2017"],"award-info":[{"award-number":["SFRH\/BD\/130913\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BioTecNorte operation","award":["NORTE-01-0145-FEDER-000004"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000004"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Predicting the sensitivity of tumors to specific anti-cancer treatments is a challenge of paramount importance for precision medicine. Machine learning(ML) algorithms can be trained on high-throughput screening data to develop models that are able to predict the response of cancer cell lines and patients to novel drugs or drug combinations. Deep learning (DL) refers to a distinct class of ML algorithms that have achieved top-level performance in a variety of fields, including drug discovery. These types of models have unique characteristics that may make them more suitable for the complex task of modeling drug response based on both biological and chemical data, but the application of DL to drug response prediction has been unexplored until very recently. The few studies that have been published have shown promising results, and the use of DL for drug response prediction is beginning to attract greater interest from researchers in the field. In this article, we critically review recently published studies that have employed DL methods to predict drug response in cancer cell lines. We also provide a brief description of DL and the main types of architectures that have been used in these studies. Additionally, we present a selection of publicly available drug screening data resources that can be used to develop drug response prediction models. Finally, we also address the limitations of these approaches and provide a discussion on possible paths for further improvement. Contact: \u00a0mrocha@di.uminho.pt<\/jats:p>","DOI":"10.1093\/bib\/bbz171","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T20:15:51Z","timestamp":1576613751000},"page":"360-379","source":"Crossref","is-referenced-by-count":199,"title":["Deep learning for drug response prediction in cancer"],"prefix":"10.1093","volume":"22","author":[{"given":"Delora","family":"Baptista","sequence":"first","affiliation":[{"name":"Biomedical Engineering at the University of Minho"}]},{"given":"Pedro G","family":"Ferreira","sequence":"additional","affiliation":[{"name":"University of Porto"}]},{"given":"Miguel","family":"Rocha","sequence":"additional","affiliation":[{"name":"Department of Informatics and a Senior Researcher of the Centre of Biological Engineering at the University of Minho"}]}],"member":"286","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"issue":"7391","key":"2021012203305454500_ref1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"D1","key":"2021012203305454500_ref2","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2021012203305454500_ref3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"issue":"11","key":"2021012203305454500_ref4","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing connectivity in a large-scale small-molecule sensitivity dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov"},{"issue":"7391","key":"2021012203305454500_ref5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"issue":"3","key":"2021012203305454500_ref6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"issue":"12","key":"2021012203305454500_ref7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nbt.3052","article-title":"A community computational challenge to predict the activity of pairs of compounds","volume":"32","author":"Bansal","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2021012203305454500_ref8","first-page":"2019","article-title":"Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen","volume":"10","author":"Menden","year":"2674","journal-title":"Nat Commun"},{"issue":"10","key":"2021012203305454500_ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0186906","article-title":"Open source machine-learning algorithms for the prediction of optimal cancer drug therapies","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"2021012203305454500_ref10","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nbt.2877","article-title":"A community effort to assess and improve drug sensitivity prediction algorithms","volume":"32","author":"Costello","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"17","key":"2021012203305454500_ref11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/bioinformatics\/btu464","article-title":"Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning","volume":"30","author":"G\u00f6nen","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"2021012203305454500_ref12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/bioinformatics\/btv529","article-title":"Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel","volume":"32","author":"Cort\u00e9s-Ciriano","year":"2015","journal-title":"Bioinformatics"},{"issue":"57","key":"2021012203305454500_ref13","doi-asserted-by":"crossref","first-page":"97025","DOI":"10.18632\/oncotarget.20923","article-title":"Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours","volume":"8","author":"Naulaerts","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2021012203305454500_ref14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005308","article-title":"A computational approach for identifying synergistic drug combinations","volume":"13","author":"Gayvert","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"2021012203305454500_ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061318","article-title":"Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties","volume":"8","author":"Menden","year":"2013","journal-title":"PLoS One"},{"key":"2021012203305454500_ref16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coisb.2018.07.001","article-title":"How to find the right drug for each patient? Advances and challenges in pharmacogenomics","volume":"10","author":"Kalamara","year":"2018","journal-title":"Curr Opin Syst Biol"},{"issue":"16","key":"2021012203305454500_ref17","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jcc.24764","article-title":"Deep learning for computational chemistry","volume":"38","author":"Goh","year":"2017","journal-title":"J Comput Chem"},{"issue":"2","key":"2021012203305454500_ref18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/ci500747n","article-title":"Deep neural nets as a method for quantitative structure\u2013activity relationships","volume":"55","author":"Ma","year":"2015","journal-title":"J Chem Inf Model"},{"issue":"1","key":"2021012203305454500_ref19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13321-017-0232-0","article-title":"Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set","volume":"9","author":"Lenselink","year":"2017","journal-title":"J Chem"},{"issue":"1","key":"2021012203305454500_ref20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13321-017-0226-y","article-title":"Deep-learning: investigating deep neural networks hyper-parameters and comparison of performance to shallow methods for modeling bioactivity data","volume":"9","author":"Koutsoukas","year":"2017","journal-title":"J Chem"},{"key":"2021012203305454500_ref21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fenvs.2015.00080","article-title":"DeepTox: toxicity prediction using deep learning","volume":"3","author":"Mayr","year":"2016","journal-title":"Front Environ Sci"},{"issue":"12","key":"2021012203305454500_ref22","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/acs.molpharmaceut.7b00578","article-title":"Comparison of deep learning with multiple machine learning methods and metrics using diverse drug discovery data sets","volume":"14","author":"Korotcov","year":"2017","journal-title":"Mol Pharm"},{"issue":"7553","key":"2021012203305454500_ref23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"2021012203305454500_ref24","article-title":"Neural machine translation by jointly learning to align and translate","author":"Bahdanau"},{"issue":"1","key":"2021012203305454500_ref25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-pharmtox-010510-100502","article-title":"Omics and drug response","volume":"53","author":"Meyer","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2021012203305454500_ref26","first-page":"841","article-title":"On Discriminative vs. Generative Classifiers: A comparison of logistic regression and naive Bayes","author":"Ng","year":"2002"},{"key":"2021012203305454500_ref27","volume-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"issue":"1","key":"2021012203305454500_ref28","first-page":"1929","article-title":"Dropout: a simple way to prevent neural networks from overfitting","volume":"15","author":"Srivastava","year":"2014","journal-title":"J Mach Learn Res"},{"issue":"11","key":"2021012203305454500_ref29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"2021012203305454500_ref30","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The Elements of Statistical Learning: Data Mining, Inference, and Prediction","author":"Hastie","year":"2009"},{"key":"2021012203305454500_ref31","volume-title":"Foundations of Machine Learning","author":"Mohri","year":"2012"},{"issue":"8","key":"2021012203305454500_ref32","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.drudis.2018.05.010","article-title":"Machine learning in chemoinformatics and drug discovery","volume":"23","author":"Lo","year":"2018","journal-title":"Drug Discov Today"},{"issue":"2","key":"2021012203305454500_ref33","first-page":"399","article-title":"Convolutional networks on graphs for learning molecular fingerprints","volume":"56","author":"Duvenaud","year":"2015","journal-title":"J Chem Inf Model"},{"key":"2021012203305454500_ref34","first-page":"423","article-title":"Multimodal Machine Learning: A Survey and Taxonomy","volume-title":"IEEE Trans Pattern Anal Mach Intell","author":"Baltrusaitis","year":"2019"},{"key":"2021012203305454500_ref35","volume-title":"Deep Learning","author":"Goodfellow","year":"2016"},{"issue":"8","key":"2021012203305454500_ref36","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1109\/TPAMI.2013.50","article-title":"Representation learning: a review and new perspectives","volume":"35","author":"Bengio","year":"2013","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"2021012203305454500_ref37","article-title":"A method for stochastic optimization. In: 3rd International Conference on Learning Representations, ICLR 2015, San Diego, CA, USA, May 7-9, 2015, Conference Track Proceedings","author":"Kingma","year":"2015"},{"key":"2021012203305454500_ref38","first-page":"448","article-title":"Deep Boltzmann machines. In: Proceedings of the Twelfth International Conference on Artificial Intelligence and Statistics, AISTATS 2009, Clearwater Beach, Florida, USA","author":"Salakhutdinov","year":"2009"},{"issue":"9","key":"2021012203305454500_ref39","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"DeepSynergy: predicting anti-cancer drug synergy with deep learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"issue":"11","key":"2021012203305454500_ref40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1109\/35.41400","article-title":"Handwritten digit recognition: applications of neural network chips and automatic learning","volume":"27","author":"Le Cun","year":"1989","journal-title":"IEEE Commun Mag"},{"issue":"141","key":"2021012203305454500_ref41","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0387","article-title":"Opportunities and obstacles for deep learning in biology and medicine","volume":"15","author":"Ching","year":"2018","journal-title":"J R Soc Interface"},{"issue":"1","key":"2021012203305454500_ref42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13321-019-0364-5","article-title":"KekuleScope: prediction of cancer cell line sensitivity and compound potency using convolutional neural networks trained on compound images","volume":"11","author":"Cort\u00e9s-Ciriano","year":"2019","journal-title":"J Chem"},{"key":"2021012203305454500_ref43","article-title":"A Critical review of recurrent neural networks for sequence","author":"Lipton","year":"2015","journal-title":"Learning"},{"key":"2021012203305454500_ref44","article-title":"PaccMann: prediction of anticancer compound sensitivity with multi-modal attention-based neural networks","author":"Oskooei","year":"2018"},{"issue":"1","key":"2021012203305454500_ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1561\/2200000006","article-title":"Learning deep architectures for AI","volume":"2","author":"Bengio","year":"2009","journal-title":"Found Trends Mach Learn"},{"issue":"5786","key":"2021012203305454500_ref46","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1126\/science.1127647","article-title":"Reducing the dimensionality of data with neural networks","volume":"313","author":"Hinton","year":"2006","journal-title":"Science"},{"issue":"2","key":"2021012203305454500_ref47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/1541-7786.MCR-17-0378","article-title":"Precision oncology beyond targeted therapy: combining omics data with machine learning matches the majority of cancer cells to effective therapeutics","volume":"16","author":"Ding","year":"2018","journal-title":"Mol Cancer Res"},{"key":"2021012203305454500_ref48","first-page":"1","article-title":"DeepDSC: a deep learning method to predict drug sensitivity of cancer cell lines","author":"Li","year":"2019","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"S1","key":"2021012203305454500_ref49","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-018-0460-9","article-title":"Predicting drug response of tumors from integrated genomic profiles by deep neural networks","volume":"12","author":"Chiu","year":"2019","journal-title":"BMC Med Genomics"},{"key":"2021012203305454500_ref50","article-title":"Auto-encoding variational bayes","author":"Kingma","year":"2013"},{"issue":"7","key":"2021012203305454500_ref51","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1162\/neco.2006.18.7.1527","article-title":"A fast learning algorithm for deep belief nets","volume":"18","author":"Hinton","year":"2006","journal-title":"Neural Comput"},{"key":"2021012203305454500_ref52","article-title":"Information processing in dynamical systems: foundations of harmony theory","author":"Smolensky","year":"1986"},{"key":"2021012203305454500_ref53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jbi.2018.07.024","article-title":"Predict effective drug combination by deep belief network and ontology fingerprints","volume":"85","author":"Chen","year":"2018","journal-title":"J Biomed Inform"},{"key":"2021012203305454500_ref54","first-page":"8024","article-title":"Pytorch: An imperative style, high-performance deep learning library","author":"Paszke","year":"2017"},{"issue":"4","key":"2021012203305454500_ref55","first-page":"486","article-title":"TensorFlow: large-scale machine learning on heterogeneous distributed systems","volume":"16","author":"Abadi","year":"2016","journal-title":"Nat Neurosci"},{"key":"2021012203305454500_ref56","volume-title":"Keras","author":"Chollet","year":"2015"},{"key":"2021012203305454500_ref57","volume-title":"Deep Learning for the Life Sciences","author":"Ramsundar","year":"2019"},{"issue":"10","key":"2021012203305454500_ref58","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat Rev"},{"issue":"9","key":"2021012203305454500_ref59","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1158\/0008-5472.CAN-09-3788","article-title":"Molecular target class is predictive of in vitro response profile","volume":"70","author":"Greshock","year":"2010","journal-title":"Cancer Res"},{"issue":"7757","key":"2021012203305454500_ref60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"issue":"5","key":"2021012203305454500_ref61","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat Med"},{"issue":"7603","key":"2021012203305454500_ref62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature17987","article-title":"Reproducible pharmacogenomic profiling of cancer cell line panels","volume":"533","author":"Haverty","year":"2016","journal-title":"Nature"},{"issue":"7631","key":"2021012203305454500_ref63","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1038\/nature20171","article-title":"Consistency in drug response profiling","volume":"540","author":"Mpindi","year":"2016","journal-title":"Nature"},{"issue":"6","key":"2021012203305454500_ref64","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O\u2019Neil","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"2021012203305454500_ref65","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","article-title":"The National Cancer Institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity","volume":"77","author":"Holbeck","year":"2017","journal-title":"Cancer Res"},{"issue":"3","key":"2021012203305454500_ref66","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.celrep.2013.07.018","article-title":"Global proteome analysis of the NCI-60 cell line panel","volume":"4","author":"Gholami","year":"2013","journal-title":"Cell Rep"},{"issue":"5795","key":"2021012203305454500_ref67","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"issue":"6","key":"2021012203305454500_ref68","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"issue":"1","key":"2021012203305454500_ref69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cels.2017.11.001","article-title":"The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations","volume":"6","author":"Keenan","year":"2018","journal-title":"Cell Syst"},{"issue":"D1","key":"2021012203305454500_ref70","doi-asserted-by":"crossref","first-page":"D558","DOI":"10.1093\/nar\/gkx1063","article-title":"Data portal for the library of integrated network-based cellular signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data","volume":"46","author":"Koleti","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2021012203305454500_ref71","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cels.2018.03.012","article-title":"A library of phosphoproteomic and chromatin signatures for characterizing cellular responses to drug perturbations","volume":"6","author":"Litichevskiy","year":"2018","journal-title":"Cell Syst"},{"issue":"7","key":"2021012203305454500_ref72","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djt007","article-title":"The clinical relevance of cancer cell lines","volume":"105","author":"Gillet","year":"2013","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"2021012203305454500_ref73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-15-0189","article-title":"Tumor-derived cell lines as molecular models of cancer pharmacogenomics","volume":"14","author":"Goodspeed","year":"2016","journal-title":"Mol Cancer Res"},{"issue":"11","key":"2021012203305454500_ref74","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"2021012203305454500_ref75","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"issue":"12","key":"2021012203305454500_ref76","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman","year":"2016","journal-title":"N Engl J Med"},{"key":"2021012203305454500_ref77","doi-asserted-by":"crossref","first-page":"bar026","DOI":"10.1093\/database\/bar026","article-title":"International cancer genome consortium data portal\u2014a one-stop shop for cancer genomics data","volume":"2011","author":"Zhang","year":"2011","journal-title":"Database"},{"issue":"D1","key":"2021012203305454500_ref78","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2021012203305454500_ref79","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2021012203305454500_ref80","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2021012203305454500_ref81","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2021012203305454500_ref82","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkx1121","article-title":"The IUPHAR\/BPS guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY","volume":"46","author":"Harding","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2021012203305454500_ref83","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021012203305454500_ref84","article-title":"Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies","volume":"1","author":"Cowley","year":"2014","journal-title":"Sci Data"},{"issue":"3","key":"2021012203305454500_ref85","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"issue":"4","key":"2021012203305454500_ref86","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.2012.96","article-title":"Pharmacogenomics knowledge for personalized medicine","volume":"92","author":"Whirl-Carrillo","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"2021012203305454500_ref87","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3299","article-title":"Prediction of human population responses to toxic compounds by a collaborative competition","volume":"33","author":"Eduati","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2021012203305454500_ref88","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"2021012203305454500_ref89","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01952257","article-title":"Effect of combinations: mathematical basis of problem","volume":"114","author":"Loewe","year":"1926","journal-title":"Arch Exp Pathol Pharmakol"},{"issue":"3","key":"2021012203305454500_ref90","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"2021012203305454500_ref91","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1093\/bioinformatics\/btz158","article-title":"Dr.VAE: improving drug response prediction via modeling of drug perturbation effects","volume":"35","author":"Ramp\u00e1\u0161ek","year":"2019","journal-title":"Bioinformatics"},{"issue":"14","key":"2021012203305454500_ref92","doi-asserted-by":"crossref","first-page":"i501","DOI":"10.1093\/bioinformatics\/btz318","article-title":"MOLI: multi-omics late integration with deep neural networks for drug response prediction","volume":"35","author":"Sharifi-Noghabi","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"2021012203305454500_ref93","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-019-2910-6","article-title":"Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network","volume":"20","author":"Liu","year":"2019","journal-title":"BMC Bioinformatics"},{"issue":"Suppl 3","key":"2021012203305454500_ref94","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12859-018-2060-2","article-title":"Investigation of model stacking for drug sensitivity prediction","volume":"19","author":"Matlock","year":"2018","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"2021012203305454500_ref95","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ygeno.2018.07.002","article-title":"Drug response prediction by ensemble learning and drug-induced gene expression signatures","volume":"111","author":"Tan","year":"2018","journal-title":"Genomics"},{"issue":"1","key":"2021012203305454500_ref96","article-title":"Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature","volume":"8","author":"Chang","year":"2018","journal-title":"Sci Rep"},{"issue":"S18","key":"2021012203305454500_ref97","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-018-2509-3","article-title":"Predicting tumor cell line response to drug pairs with deep learning","volume":"19","author":"Xia","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"2021012203305454500_ref98","article-title":"SMILES enumeration as data augmentation for neural network modeling of molecules","author":"Bjerrum","year":"2017"},{"key":"2021012203305454500_ref99","first-page":"248","article-title":"ImageNet: a large-scale hierarchical image database","volume-title":"2009 IEEE Conf. Comput. Vis. Pattern Recognit.","author":"Deng","year":"2009"},{"issue":"10","key":"2021012203305454500_ref100","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 3","key":"2021012203305454500_ref101","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1752-0509-6-S3-S3","article-title":"Signaling network prediction by the ontology fingerprint enhanced Bayesian network","volume":"6","author":"Qin","year":"2012","journal-title":"BMC Syst Biol"},{"issue":"1","key":"2021012203305454500_ref102","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pharmtox-010919-023537","article-title":"Using what we already have: uncovering new drug repurposing strategies in existing omics data","volume":"60","author":"Pulley","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"2021012203305454500_ref103","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acs.molpharmaceut.6b00248","article-title":"Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data","volume":"13","author":"Aliper","year":"2016","journal-title":"Mol Pharm"},{"issue":"10","key":"2021012203305454500_ref104","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1021\/acs.molpharmaceut.8b00284","article-title":"Drug repurposing using deep embeddings of gene expression profiles","volume":"15","author":"Donner","year":"2018","journal-title":"Mol Pharm"},{"key":"2021012203305454500_ref105","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btz418","article-title":"deepDR: a network-based deep learning approach to in silico drug repositioning","author":"Zeng","year":"2019","journal-title":"Bioinformatics"},{"issue":"8","key":"2021012203305454500_ref106","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10822-016-9938-8","article-title":"Molecular graph convolutions: moving beyond fingerprints","volume":"30","author":"Kearnes","year":"2016","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"2021012203305454500_ref107","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1039\/C7SC02664A","article-title":"MoleculeNet: a benchmark for molecular machine learning","volume":"9","author":"Wu","year":"2018","journal-title":"Chem Sci"},{"key":"2021012203305454500_ref108","first-page":"285","article-title":"Seq2seq Fingerprint","volume-title":"Proc. 8th ACM Int. Conf. Bioinformatics, Comput. Biol. Heal. Informatics - ACM-BCB \u201917","author":"Xu","year":"2017"},{"issue":"24","key":"2021012203305454500_ref109","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1039\/C8SC00148K","article-title":"Large-scale comparison of machine learning methods for drug target prediction on ChEMBL","volume":"9","author":"Mayr","year":"2018","journal-title":"Chem Sci"},{"issue":"10","key":"2021012203305454500_ref110","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1021\/acs.molpharmaceut.7b01144","article-title":"Geometric deep learning autonomously learns chemical features that outperform those engineered by domain experts","volume":"15","author":"Hop","year":"2018","journal-title":"Mol Pharm"},{"issue":"2","key":"2021012203305454500_ref111","first-page":"325","article-title":"A review on machine learning principles for multi-view biological data integration","volume":"19","author":"Li","year":"2016","journal-title":"Brief Bioinform"},{"issue":"5","key":"2021012203305454500_ref112","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/acs.molpharmaceut.5b00982","article-title":"Applications of deep learning in biomedicine","volume":"13","author":"Mamoshina","year":"2016","journal-title":"Mol Pharm"},{"issue":"7480","key":"2021012203305454500_ref113","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature12831","article-title":"Inconsistency in large pharmacogenomic studies","volume":"504","author":"Haibe-Kains","year":"2013","journal-title":"Nature"},{"key":"2021012203305454500_ref114","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.12688\/f1000research.9611.1","article-title":"Revisiting inconsistency in large pharmacogenomic studies","volume":"5","author":"Safikhani","year":"2016","journal-title":"F1000Res"},{"issue":"7580","key":"2021012203305454500_ref115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature15736","article-title":"Pharmacogenomic agreement between two cancer cell line data sets","volume":"528","author":"Cancer Cell Line Encyclopedia Consortium, Genomics of Drug Sensitivity in Cancer Consortium","year":"2015","journal-title":"Nature"},{"issue":"7631","key":"2021012203305454500_ref116","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature19838","article-title":"Consistency in large pharmacogenomic studies","volume":"540","author":"Geeleher","year":"2016","journal-title":"Nature"},{"key":"2021012203305454500_ref117","first-page":"2672","article-title":"Generative adversarial nets","volume-title":"Adv. Neural Inf. Process. Syst. 27","author":"Goodfellow","year":"2014"},{"issue":"1","key":"2021012203305454500_ref118","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eng.2018.11.018","article-title":"Wasserstein GAN-based small-sample augmentation for new-generation artificial intelligence: a case study of cancer-staging data in biology","volume":"5","author":"Liu","year":"2019","journal-title":"Engineering"},{"key":"2021012203305454500_ref119","first-page":"3645","article-title":"Energy and policy considerations for deep learning in NLP","author":"Strubell","year":"2019"},{"key":"2021012203305454500_ref120","article-title":"Green AI","author":"Schwartz","year":"2019"},{"key":"2021012203305454500_ref121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1109\/DSAA.2018.00018","article-title":"Explaining Explanations: An Overview of Interpretability of Machine Learning","volume-title":"2018 IEEE 5th International Conference on Data Science and Advanced Analytics (DSAA)","author":"Gilpin","year":"2018"},{"key":"2021012203305454500_ref122","first-page":"1135","article-title":"\u201dWhy Should I Trust You?\u201d: Explaining the Predictions of Any Classifier","volume-title":"Proc 22nd ACM SIGKDD Int Conf Knowl Discov Data Min - KDD \u201916","author":"Ribeiro","year":"2016"},{"key":"2021012203305454500_ref123","article-title":"Dropout feature ranking for deep learning models","author":"Chang","year":"2017"},{"key":"2021012203305454500_ref124","first-page":"3145","article-title":"Learning important features through propagating activation differences","volume-title":"Proc. 34th Int. Conf. Mach. Learn. 70","author":"Shrikumar","year":"2017"},{"key":"2021012203305454500_ref125","first-page":"3319","article-title":"Axiomatic attribution for deep networks","volume-title":"Proceedings of the 34th International Conference on Machine Learning\u2014Volume 70, JMLR.org2017, ICML\u201917","author":"Sundararajan"},{"key":"2021012203305454500_ref126","first-page":"4765","article-title":"A unified approach to interpreting model predictions","volume-title":"Adv. Neural Inf. Process. Syst. 30","author":"Lundberg","year":"2017"},{"key":"2021012203305454500_ref127","first-page":"307","article-title":"A value for n-person games","volume-title":"Contributions to the Theory of Games (AM-28)","author":"Shapley","year":"1953"},{"issue":"4","key":"2021012203305454500_ref128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03037089","article-title":"Inductive logic programming","volume":"8","author":"Muggleton","year":"1991","journal-title":"New Gener Comput"},{"key":"2021012203305454500_ref129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1613\/jair.5714","article-title":"Learning explanatory rules from noisy data","volume":"61","author":"Evans","year":"2018","journal-title":"J Artif Intell Res"},{"issue":"5","key":"2021012203305454500_ref130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","article-title":"Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead","volume":"1","author":"Rudin","year":"2019","journal-title":"Nat Mach Intell"},{"key":"2021012203305454500_ref131","first-page":"7775","article-title":"Towards robust interpretability with self-explaining neural networks","volume-title":"Advances in Neural Information Processing Systems 31","author":"Alvarez Melis","year":"2018"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/1\/360\/35934938\/bbz171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/1\/360\/35934938\/bbz171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T04:07:31Z","timestamp":1695528451000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/22\/1\/360\/5707551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,17]]},"published-print":{"date-parts":[[2021,1,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbz171","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,1,17]]}}}